BiotechTube
Home/Rezq Bio/Howard Foyt, MD, PhD
HF

Howard Foyt, MD, PhD

CMO

Rezq Bio

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesType 1 Diabetes

Rezq Bio Pipeline

DrugIndicationPhase
RZQ-MC1Early Onset Type 1 DiabetesPhase 1B/2A
RZQ-MC2Colitis/IBDPreclinical
RZQ-CC1Transplant/Implant SupportPreclinical
RZQ-MM*Type 1 DiabetesPreclinical

Leadership Team at Rezq Bio

AH
Arjun Hattiangadi
CEO and Founder
NG
Nick Giannoukakis, PhD
CSO and Founder
DG
Doug Greene, MD
Head of R&D
EL
Elina Linetsky, PhD
VP of Process, Development and Manufacturing
View full Rezq Bio profile